Targeting PIKfyve-driven lipid metabolism in pancreatic cancer
Caleb Cheng(University of Michigan), Arul M. Chinnaiyan(University of Michigan), Jennifer P. Morton(Cancer Research UK), Jasmine P. Wisniewski(University of Michigan), Nicholas J. Rossiter(University of Michigan), Somnath Mahapatra(University of Michigan), Xuhong Cao(Howard Hughes Medical Institute), Rupam Bhattacharyya(University of Michigan), Yatrik M. Shah(University of Michigan), Saadia A. Karim, Brian Magnuson(University of Michigan), Rahul Mannan(University of Michigan), Dominik Awad(The University of Texas MD Anderson Cancer Center), Yi Bao(Stevens Institute of Technology), Pietro Morlacchi(Agilent Technologies (United States)), Rohit Mehra(University of Michigan–Ann Arbor), Yuping Zhang(University of Michigan), Marina Pasca di Magliano(OncoMed (United States)), Tongchen He(University of Michigan), Vaibhav Sahai(University of Michigan–Ann Arbor), Chungen Li(Chinese Academy of Sciences), David MacLean, Lois S. Weisman(University of Michigan), Costas A. Lyssiotis(University of Michigan), Hüseyin Karabürk(University of Michigan), Zhen Wang(Shanghai Institute of Organic Chemistry), Li Zhang(Fourth Hospital of Changsha), Yang Zheng(Shanghai Ninth People's Hospital), Jing Hu(University of Michigan), Sydney Peters(University of Michigan), Ke Ding(China Pharmaceutical University), Lanbo Xiao(University of Michigan), Yuanyuan Qiao(University of Michigan)
Cited by 37
Related Papers
Integrative Clinical Genomics of Advanced Prostate Cancer
|Cell|2015|3.6k
DNA-Repair Defects and Olaparib in Metastatic Prostate Cancer
|New England Journal of Medicine|2015|2.2k
Oncogenic Kras Maintains Pancreatic Tumors through Regulation of Anabolic Glucose Metabolism
|Cell|2012|2k
Activating ESR1 mutations in hormone-resistant metastatic breast cancer
|Nature Genetics|2013|1.2k